Editorial: Covid-19 therapies in patients with hematologic malignancies

• Andrea Visentin,
• Massimo Gentile,
• Massimo Gentile

Affiliations

Andrea Visentin

Hematology Unit, Department of Medicine, University of Padova, Padova, Italy

Massimo Gentile

Hematology Unit, Azienda Ospedaliera (AO) Cosenza, Cosenza, Italy

Massimo Gentile

Department of Pharmacy, Health and Nutritional Science, University of Calabria, Rende, Italy